Apollo Global Management APO
$116.75 −$0.52 (-0.44%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $116.01 -0.63%
Open$117.44
Prev close$117.27
Day range$115.65 – $118.79
Volume3.32M
Market cap$68.93B
P/E (TTM)–
Dividend yield1.84%
APO Stock News
Headlines matching Apollo Global Management or the APO ticker, most recent first.
- Apollo Global Management (APO.US) is reportedly in talks to acquire Johnson & Johnson's (JNJ.US) orthopedics business, with the potential deal valued at nearly $20 billion.
- Barclays Maintains Apollo Global Management(APO.US) With Buy Rating, Maintains Target Price $157
- J.P. Morgan Maintains Apollo Global Management(APO.US) With Buy Rating, Raises Target Price to $154 Positive
- Reports suggest Apollo Global Management (APO.US) is considering raising its loan to SoftBank to $9 billion to support investments in OpenAI.
- Barclays Maintains Apollo Global Management(APO.US) With Buy Rating, Maintains Target Price $157
- TD Cowen Maintains Apollo Global Management(APO.US) With Buy Rating, Maintains Target Price $159
- Analysts Offer Insights on NA Companies: Concentra Group Holdings Parent, Inc. (CON) and Apollo Global Management (APO)
- BofA Securities Maintains Apollo Global Management(APO.US) With Buy Rating
- TD Cowen Maintains Apollo Global Management(APO.US) With Buy Rating, Raises Target Price to $159 Positive
- RBC Capital Maintains Apollo Global Management(APO.US) With Hold Rating, Raises Target Price to $146 Positive
- Morgan Stanley Maintains Apollo Global Management(APO.US) With Buy Rating, Maintains Target Price $164
- UBS Maintains Apollo Global Management(APO.US) With Buy Rating, Raises Target Price to $172 Positive
- Analysts Offer Insights on NA Companies: SpaceX (SPCX), Apollo Global Management (APO) and Concentra Group Holdings Parent, Inc. (CON)
- Barclays Maintains Apollo Global Management(APO.US) With Buy Rating, Raises Target Price to $157 Positive
- Analysts Offer Insights on NA Companies: Apollo Global Management (APO), Fermi Inc. (FRMI) and Arrive AI Inc. (ARAI)
No comments yet — be the first to weigh in on APO.
Sign in to join the discussion.